HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Masamune Selected Research

Chronic Pancreatitis

6/2009A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
4/2009Fibrinogen induces cytokine and collagen production in pancreatic stellate cells.
7/2001Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors.
1/2001Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Masamune Research Topics

Disease

7Pancreatitis
06/2009 - 02/2000
4Pancreatic Neoplasms (Pancreatic Cancer)
06/2009 - 07/2001
4Chronic Pancreatitis
06/2009 - 01/2001
2Neoplasms (Cancer)
10/2001 - 07/2001
2Carcinoma (Carcinomatosis)
10/2001 - 07/2001
2Necrosis
09/2001 - 01/2001
1Gastroesophageal Reflux (GERD)
01/2021
1Fibrosis (Cirrhosis)
03/2009
1False Aneurysm (Pseudoaneurysm)
11/2001
1Hereditary pancreatitis
11/2001
1Inflammation (Inflammations)
08/2001
1Stomach Neoplasms (Stomach Cancer)
08/2001
1Carcinogenesis
07/2001
1Adenoma (Adenomas)
07/2001
1Adenocarcinoma
07/2001
1Multiple Organ Failure (MODS)
05/2001
1Lung Injury
05/2001
1Edema (Dropsy)
09/2000
1Acute Hemorrhagic Pancreatitis
04/2000
1Ascites
02/2000

Drug/Important Bio-Agent (IBA)

3NF-kappa B (NF-kB)IBA
09/2001 - 05/2001
2TrypsinogenIBA
06/2009 - 11/2001
2Proteins (Proteins, Gene)FDA Link
04/2009 - 07/2001
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
09/2001 - 01/2001
2Phospholipases A2 (Phospholipase A2)IBA
09/2001 - 01/2001
2We 201IBA
09/2001 - 01/2001
2Transcription Factors (Transcription Factor)IBA
09/2001 - 02/2000
2Phospholipids (Phosphatides)FDA LinkGeneric
09/2001 - 01/2001
2Interleukin-8 (Interleukin 8)IBA
08/2001 - 02/2000
2CeruletideIBA
05/2001 - 09/2000
2Taurocholic Acid (Sodium Taurocholate)IBA
09/2000 - 04/2000
1GastrinsIBA
01/2021
1Proton Pump InhibitorsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
06/2009
1Peptide Hydrolases (Proteases)FDA Link
06/2009
1Fibrinogen (Factor I)FDA Link
04/2009
1Antifibrotic AgentsIBA
03/2009
1LigandsIBA
10/2001
1Apoptosis Inducing FactorIBA
10/2001
1thiazolyl blueIBA
10/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001
1CeramidesIBA
08/2001
1rebamipideIBA
08/2001
1SurvivinIBA
07/2001
1Kazal Pancreatic Trypsin InhibitorIBA
01/2001
1AmylasesFDA Link
09/2000
1Adenosine (Adenocard)FDA LinkGeneric
09/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2000
1InterleukinsIBA
02/2000
1CytokinesIBA
02/2000
1Interleukin-6 (Interleukin 6)IBA
02/2000

Therapy/Procedure

2Therapeutics
01/2021 - 03/2009
1Drug Therapy (Chemotherapy)
03/2009
1Conservative Treatment
11/2001